<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158039">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01858493</url>
  </required_header>
  <id_info>
    <org_study_id>ERA-AGE2 dossier28835</org_study_id>
    <nct_id>NCT01858493</nct_id>
  </id_info>
  <brief_title>Continence Across Continents to Upend Stigma and Dependency</brief_title>
  <acronym>CACTUS-D</acronym>
  <official_title>Phase 3 Cluster Randomised Trial Testing the Efficacy of a Continence Promotion Intervention to Improve Urinary Symptoms and Quality of Life, and Reduce Stigma and Falls in Older Community-dwelling Women With Untreated Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research  (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut national de prevention et d'education pour la sante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</source>
  <oversight_info>
    <authority>Quebec: Fonds de recherche en sante de Quebec</authority>
    <authority>Canada: Canadian Institutes of Health Research</authority>
    <authority>United Kingdom: Economic and Social Research Council</authority>
    <authority>France: Institut national de prevention et d'education pour la sante</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether women exposed to the continence promotion intervention will report
      improved urinary symptoms and quality of life, and lower incontinence-related stigma and
      falls than women who receive a control intervention at one-year post-intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cluster-randomized 4-site intervention study testing the effect of a
      continence-promotion intervention on:

        1. Improved urinary symptoms and quality of life

        2. Reduction in falls

        3. Reduction in stigma

      A cost-effectiveness component will also be included
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Self-reported improvement in urinary incontinence</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient global impression of improvement questionnaire Sandvik severity index ICIQ-FLUTS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Falls</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction in incontinence-related falls measured by fall diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in incontinence related stigma and quality of life</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured with the Incontinence Quality of Life questionnaire (IQOL)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cost-utility of the continence promotion intervention</measure>
    <time_frame>1-year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cost/QALY. Direct costs will include costs related to the intervention as well as health care resource use due to incontinence-associated falls and health care seeking for incontinence will be measured. Indirect costs will be measured such as the time lost from work for a child or spouse to accompany the participant to receive medical treatment for incontinence or falls. The change in utility from the baseline incontinent condition to improved incontinence with increased social participation and decreased stigma on quality of life will be calculated from SF6D utilities derived from the SF-12 questionnaire at baseline and 1-year follow-up. A disease-specific measure, the IQOL is currently undergoing mapping onto the SF-6D to see if it will provide a more responsive indication of improved quality of life than the generic SF-12 measure.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Urinary Incontinence</condition>
  <condition>Falls</condition>
  <condition>Quality of Life</condition>
  <condition>Stigma</condition>
  <arm_group>
    <arm_group_label>Continence promotion group education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A single 1-hour continence promotion group education workshop, facilitated by the research coordinator, aimed at changing knowledge and beliefs about urinary incontinence and different treatment options. An evidence-based self-management tool will be distributed at the end of the workshop.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham health lecture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A single 1-hour group education workshop on other health topics of concern to older women such as memory, hearing, insomnia</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Continence promotion group education workshop</intervention_name>
    <arm_group_label>Continence promotion group education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sham health lecture</intervention_name>
    <arm_group_label>Sham health lecture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women

          -  65 years and older

          -  Urinary incontinence at least once weekly

        Exclusion Criteria:

          -  Living in residential or long-term care

          -  Received treatment for incontinence within the past year

          -  Dementia or other neurological conditions that preclude the ability to provide
             -Informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cara Tannenbaum, MD. MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univeristé de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrian Wagg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eleanor van den Heuvel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brunel University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Fritel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Poitiers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cara Tannenbaum, MD, MSc</last_name>
    <phone>5143403540</phone>
    <phone_ext>2526</phone_ext>
    <email>cara.tannenbaum@umontreal.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Wagg, MD</last_name>
      <phone>780 492 5338</phone>
      <email>wagg@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Adrian Wagg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut universitaire de gériatrie de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3W1W5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joelle Dorais, BSc</last_name>
      <phone>5143403540</phone>
      <phone_ext>4104</phone_ext>
      <email>joelle.dorais@criugm.ca</email>
    </contact>
    <investigator>
      <last_name>Cara Tannenbaum, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <state>Poitou-Charentes</state>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie Rogeon, BSc</last_name>
      <phone>05.49.44.30.44</phone>
      <phone_ext>41234</phone_ext>
      <email>Elodie.ROGEON@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier Fritel, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Brunel</name>
      <address>
        <city>Uxbridge</city>
        <state>Middlesex</state>
        <zip>UB8 3PH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleanor van den Heuvel, PhD</last_name>
      <phone>01895266921</phone>
      <email>Eleanor van den Heuvel &lt;Eleanor.van.den.Heuvel@brunel.ac.uk&gt;</email>
    </contact>
    <investigator>
      <last_name>Eleanor van den Heuvel, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Agnew R, van den Heuvel E, Tannenbaum C. Efficiency of using community organisations as catalysts for recruitment to continence promotion trials. Clin Trials. 2013 Feb;10(1):151-9. doi: 10.1177/1740774512460144. Epub 2012 Oct 5.</citation>
    <PMID>23043154</PMID>
  </reference>
  <reference>
    <citation>Tannenbaum C, Agnew R, Benedetti A, Thomas D, van den Heuvel E. Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial. BMJ Open. 2013 Dec 10;3(12):e004135. doi: 10.1136/bmjopen-2013-004135.</citation>
    <PMID>24334159</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 31, 2014</lastchanged_date>
  <firstreceived_date>May 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal</investigator_affiliation>
    <investigator_full_name>Cara Tannenbaum</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Urinary incontinence</keyword>
  <keyword>Falls</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Stigma</keyword>
  <keyword>Community-dwelling older women</keyword>
  <keyword>Continence promotion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Urinary Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
